Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, Mark E., Pu, Haifeng, Chiu, Arlene Y., Dal Canto, Mauro C., Polchow, Cynthia Y., Alexander, Denise D., Caliendo, Jan, Hentati, Afif +6 more·1994·Science
DOI 10.1126/science.8209258

Cited by (138)

Items 101–138 of 138

  1. Antisense drugs make sense for neurological diseases
    Bennett, C. Frank, Kordasiewicz, Holly B., Cleveland, Don W. · 2021 · Annual Review of Pharmacology and Toxicology
  2. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
  3. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis
    Solomon, Jennifer N., Lewis, Coral‐Ann B., Ajami, Bahareh, Corbel, Stephane Y., Rossi, Fabio M.V., Krieger, Charles · 2006 · Glia
  4. Mitochondrial calcium cycling in neuronal function and neurodegeneration
    Walters, Grant C., Usachev, Yuriy M. · 2023 · Frontiers in Cell and Developmental Biology
  5. Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
    Szeto, Hazel H. · 2008 · Annals of the New York Academy of Sciences
  6. Beyond muscles: The untapped potential of creatine
    Riesberg, Lisa A., Weed, Stephanie A., McDonald, Thomas L., Eckerson, Joan M., Drescher, Kristen M. · 2016 · International Immunopharmacology
  7. The microbiota–microglia axis in central nervous system disorders
    Mossad, Omar, Erny, Daniel · 2020 · Brain Pathology
  8. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model
    Matsumoto, Tomohiro, Imagama, Shiro, Hirano, Kenichi, Ohgomori, Tomohiro, Natori, Takamitsu, Kobayashi, Kazuyoshi, Muramoto, Akio, Ishiguro, Naoki, Kadomatsu, Kenji · 2012 · Neuroscience Letters
  9. Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1)
    Harlan, Benjamin A., Pehar, Mariana, Sharma, Deep R., Beeson, Gyda, Beeson, Craig C., Vargas, Marcelo R. · 2016 · Journal of Biological Chemistry
  10. Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice
    Figueroa-Romero, Claudia, Guo, Kai, Murdock, Benjamin J., Paez-Colasante, Ximena, Bassis, Christine M., Mikhail, Kristen A., Raue, Kristen D., Evans, Matthew C., Taubman, Ghislaine F., McDermott, Andrew J. et al. · 2019 · Disease Models & Mechanisms
  11. Creatine for neuroprotection in neurodegenerative disease: end of story?
    Bender, Andreas, Klopstock, Thomas · 2016 · Amino Acids
  12. Effects of an Inhibitor of Poly(ADP-Ribose) Polymerase, Desmethylselegiline, Trientine, and Lipoic Acid in Transgenic ALS Mice
    Andreassen, Ole A., Dedeoglu, Alpaslan, Friedlich, Avi, Ferrante, Kimberly L., Hughes, Duncan, Szabo, Cesar, Beal, M.Flint · 2001 · Experimental Neurology
  13. Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL−/− mice: Support for a role for TDP-43 in the physiological response to neuronal injury
    Moisse, Katie, Mepham, Jennifer, Volkening, Kathryn, Welch, Ian, Hill, Tracy, Strong, Michael J. · 2009 · Brain Research
  14. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
    Hawrot, James, Imhof, Sophie, Wainger, Brian J. · 2020 · Neurobiology of Disease
  15. Cortical neurotoxic astrocytes with early ALS pathology and miR-146a deficit replicate gliosis markers of symptomatic SOD1G93A mouse model
    Gomes, Cátia, Cunha, Carolina, Nascimento, Filipe, Ribeiro, Joaquim A., Vaz, Ana Rita, Brites, Dora · 2019 · Molecular Neurobiology
  16. Physical Exercise-Induced Myokines in Neurodegenerative Diseases
    Lee, Banseok, Shin, Myeongcheol, Park, Youngjae, Won, So-Yoon, Cho, Kyoung Sang · 2021 · International Journal of Molecular Sciences
  17. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
    Rossi, Chiara, Cusimano, Melania, Zambito, Martina, Finardi, Annamaria, Capotondo, Alessia, Garcia-Manteiga, Jose Manuel, Comi, Giancarlo, Furlan, Roberto, Martino, Gianvito, Muzio, Luca · 2018 · Cell Death & Disease
  18. The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells
    Lewis, Coral-Ann, Manning, John, Rossi, Fabio, Krieger, Charles · 2012 · Neurology Research International
  19. Mice deficient in NRROS show abnormal microglial development and neurological disorders
    Wong, Kit, Noubade, Rajkumar, Manzanillo, Paolo, Ota, Naruhisa, Foreman, Oded, Hackney, Jason A, Friedman, Brad A, Pappu, Rajita, Scearce-Levie, Kimberly, Ouyang, Wenjun · 2017 · Nature Immunology
  20. Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions
    Todd, Tiffany W., Petrucelli, Leonard · 2016 · Journal of Neurochemistry
  21. The mitochondrial calcium regulator cyclophilin d is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis
    Kim, Hyun Jeong, Magranè, Jordi, Starkov, Anatoly A., Manfredi, Giovanni · 2012 · Brain
  22. Differential autophagy power in the spinal cord and muscle of transgenic ALS mice
    Crippa, Valeria, Boncoraglio, Alessandra, Galbiati, Mariarita, Aggarwal, Tanya, Rusmini, Paola, Giorgetti, Elisa, Cristofani, Riccardo, Carra, Serena, Pennuto, Maria, Poletti, Angelo · 2013 · Frontiers in Cellular Neuroscience
  23. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis
    Zhang, Yongguo, Ogbu, Destiny, Garrett, Shari, Xia, Yinglin, Sun, Jun · 2021 · Gut Microbes
  24. The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
    Obrenovich, Mark, Jaworski, Hayden, Tadimalla, Tara, Mistry, Adil, Sykes, Lorraine, Perry, George, Bonomo, Robert · 2020 · Microorganisms
  25. The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
    Petri, Susanne, Calingasan, Noel Y., Alsaied, Osama A., Wille, Elizabeth, Kiaei, Mahmoud, Friedman, Jonathan E., Baranova, Oxana, Chavez, Juan C., Beal, M. Flint · 2007 · Journal of Neurochemistry
  26. A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress
    Thams, Sebastian, Lowry, Emily Rhodes, Larraufie, Marie-Hélène, Spiller, Krista J., Li, Hai, Williams, Damian J., Hoang, Phuong, Jiang, Elise, Williams, Luis A., Sandoe, Jackson et al. · 2019 · Molecular Therapy
  27. Transient systemic mtDNA damage leads to muscle wasting by reducing the satellite cell pool
    Wang, Xiao, Pickrell, Alicia M., Rossi, Susana G., Pinto, Milena, Dillon, Lloye M., Hida, Aline, Rotundo, Richard L., Moraes, Carlos T. · 2013 · Human Molecular Genetics
  28. Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1
    Harlan, Benjamin A., Pehar, Mariana, Killoy, Kelby M., Vargas, Marcelo R. · 2019 · The FASEB Journal
  29. Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
    Sun, Jiangwei, Huang, Tingting, Debelius, Justine W., Fang, Fang · 2021 · Journal of Internal Medicine
  30. Disruption of the structure of the Golgi apparatus and the function of the secretory pathway by mutants G93A and G85R of Cu, Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis
    Stieber, Anna, Gonatas, J.O., Moore, J.S., Bantly, Andrew, Yim, H.-S., Yim, M.B., Gonatas, N.K. · 2004 · Journal of the Neurological Sciences
  31. Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis
    Huang, Zhilin, Liu, Qiang, Peng, Yu, Dai, Jiaying, Xie, Youna, Chen, Weineng, Long, Simei, Pei, Zhong, Su, Huanxing, Yao, Xiaoli · 2018 · Frontiers in Neurology
  32. Approaches to gene modulation therapy for ALS
    Meijboom, Katharina E., Brown, Robert H. · 2022 · Neurotherapeutics
  33. Amyotrophic Lateral Sclerosis: Current and Future Treatment Strategies
    Festoff, Barry W. · 1996 · Drugs
  34. The role of immune-mediated alterations and disorders in ALS disease
    Rodrigues Lima-Junior, João, Sulzer, David, Lindestam Arlehamn, Cecilia S., Sette, Alessandro · 2021 · Human Immunology
  35. Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS
    Li, Xuejun, Dong, Li, Li, Ang, Yi, Jianxun, Brotto, Marco, Zhou, Jingsong · 2022 · Biomolecules
  36. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis
    Lee, Jae Chul, Shin, Ji-Hee, Park, Byeong-Woo, Kim, Gwon Sik, Kim, Jin Cheon, Kang, Kyung-Sun, Cha, Choong Ik · 2012 · Brain Research
  37. Status of ALS treatment, insights into therapeutic challenges and dilemmas
    Khamaysa, Mohammed, Pradat, Pierre-François · 2022 · Journal of Personalized Medicine
  38. Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis
    Ryu, In Soo, Ha, Dae-In, Jung, Yeon-Joo, Lee, Hyo Jin, Kim, Insun, Lim, Yu Na, Min, Hyun Su, Kim, Seung Hyun, Yoon, Ilsang, Cho, Hyun-Jeong et al. · 2026 · International Journal of Molecular Sciences